So presumably you have RAG'd each medicine based on current sourcing and procurement, according to likely Brexit outcomes and you will know which ones are at greatest risk in terms of supply...yes?
Yes. We`ve had 3 years to do it although the central format/organisation took sometime to materialise.
You will also of course as part of that scenario planning have identified the mitigation measures to make sure those risks do not materialise...true?
True. Mitigation is not an exact science.
And you will have an idea of the cost of those extra measure too..is that the case?
Yes. The majority of our contracts are fixed term and include force majeure.
And presumably that will be additional cost to that of existing supply routes...or will it save the NHS money?
Yes there will be, in certain supply routes, additional cost.
However it has also forced the NHS to look at how it works collaboratively which ties in with the Carter report.
The NHS doesn`t "do" national purchasing but that is changing with the creation of category towers and larger scale pricing agreements that Trusts can join.
Are you saying that DOH and NHS England are saying something different in their scenario planning to the consultant neurologist in question and are you saying that Govt and NHS NHS e asked the wrong people to do that work (which for most affected government departments has been going on for the best part of 18 months with direct comms between all parties often on a daily or greater basis)?...if so, someone ought to ask them really and clear up the mess, so that we're all clear and agree where the risks are....Then we can stop brushing it off as project fear.
I said the consultant neurologist probably doesn`t even know who does his hospitals procurement now or in the future. He said himself that "some of the drugs may be in short supply".